Panacos Pharmaceuticals (PANC) Stock Price & Analysis
PANC Stock Chart & Stats
- Day’s Range
- $0.05 - $0.05
- 52-Week Range
- $0.05 - $0.05
- Previous Close
- $0.05
- Volume
- 120
- Average Volume (3M)
- 0
- Market Cap
- $54
- Enterprise Value
- N/A
- Total Cash (Recent Filing)
- N/A
- Total Debt (Recent Filing)
- $8.82M
- Price to Earnings (P/E)
- 0.0
- Beta
- 0.00
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
PANC FAQ
What was Panacos Pharmaceuticals’s price range in the past 12 months?
What is Panacos Pharmaceuticals’s market cap?
When is Panacos Pharmaceuticals’s upcoming earnings report date?
Is Panacos Pharmaceuticals overvalued?
Does Panacos Pharmaceuticals pay dividends?
What is Panacos Pharmaceuticals’s EPS estimate?
How many shares outstanding does Panacos Pharmaceuticals have?
Which hedge fund is a major shareholder of Panacos Pharmaceuticals?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Panacos Pharmaceuticals
Panacos Pharmaceuticals, Inc. functions as an early-stage biotechnology firm specializing in the research and development of orally administered small-molecule therapeutics. These innovative drugs are crafted to combat human immunodeficiency virus (HIV) and various other viral diseases affecting humans. The company's scientific methodology concentrates on identifying novel targets within the viral life cycle, specifically focusing on processes like virus maturation and fusion. Currently, their product portfolio includes advanced initiatives, such as second- and third-generation programs, centered on inhibiting HIV maturation. Founded in 1999, the company's main operations are situated in Watertown, Massachusetts.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- John R. Barr
- Employees
- 41
- Website
- www.panacos.com
- Address
- 134 Coolidge Avenue, Watertown, MA, 02472, US
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 3 | 2 |
| Technical Analysis | 0 | 1 | 0 |
| Moving Averages | 6 | 2 | 2 |